The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis

Background: Alzheimer's disease (AD) diagnoses once depended on neuropathologic examination. Now, many widely used, validated biomarkers benefits for monitoring of AD neuropathologic changes. Exosome-derived biomarker studies have reported them to be significantly related to AD's early occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Wenmin, Gao, Wenyan, Lv, Xiaoling, Xu, Xiaogang, Zhang, Zhongshan, Yan, Jing, Mao, Genxiang, Bu, Zhibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957006/
https://www.ncbi.nlm.nih.gov/pubmed/33732139
http://dx.doi.org/10.3389/fnagi.2021.637218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957006/
https://www.ncbi.nlm.nih.gov/pubmed/33732139
http://dx.doi.org/10.3389/fnagi.2021.637218

Ejemplares similares